Donepezil Hydrochloride
Product Images NDC 68554-5038

Product Visual Gallery

This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Donepezil Hydrochloride (NDC 68554-5038). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hetero Labs Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1.jpg (Figure1)

FDA Label Image

Figure10.jpg (Figure10)

FDA Label Image

Figure2.jpg (Figure2)

FDA Label Image

Figure3.jpg (Figure3)

This appears to be a graph showcasing the percentage of patients and their corresponding improvement ratings when taking Aricept 10 mg/day or 5 mg/day compared to placebo. The improvement ratings are categorized as "markedly improved", "moderately improved", "minimally improved", "no change", "minimally worse", "moderately worse", and "markedly worse". However, without additional context, it is difficult to determine what Aricept is or what condition it is being used to treat.*

FDA Label Image

Figure4.jpg (Figure4)

FDA Label Image

Figure5.jpg (Figure5)

FDA Label Image

Figure6.jpg (Figure6)

FDA Label Image

Figure7.jpg (Figure7)

FDA Label Image

Figure8.jpg (Figure8)

FDA Label Image

Figure9.jpg (Figure9)

FDA Label Image

Label1.jpg (Label1)

Donepezil Hydrochloride Tablets is a medication containing 5 mg of donepezil hydrochloride USP per film-coated tablet. It is dispensed in tight containers and should be stored at a temperature between 20° to 25°C. The usual dosage information can be found in the package insert. Pharmacists are advised to give the patient package insert to every patient. It comes in a prescription-only bottle of 30 tablets and is manufactured by Hetero Labs Limited in India.*

FDA Label Image

Label2.jpg (Label2)

This is a description of a medication called Donepezil Hydrochloride. It is available in the form of tablets, each tablet containing 10 mg of the medication. The usual dosage should be checked in the package insert that comes along with the medication. It should be stored in tight containers at a temperature between 20-25°C. Pharmacists are required to dispense the accompanying patient package insert to each patient. The medication is manufactured by HETERO LABS LIMITED in India. The information related to the product's National Drug Code (NDC) and manufacturing license number are also provided.*

FDA Label Image

Label3.jpg (Label3)

This appears to be the label information for Donepezil Hydrochloride Tablets, USP, including dosage information, manufacturing information, and storage instructions. The tablets contain 5mg Mig with hydrochloride USP, and the label contains the Lot Number and Expiry. It is recommended to be stored in tight containers at room temperature.*

FDA Label Image

Label4.jpg (Label4)

This is a package of Donepezil Hydrochloride Tablets, USP. The packaging contains important information such as the dosage, manufacturer, and batch number. The tablets are usually dispensed in fight containers and contain 10 mg of donepezil hydrochloride USP. The package insert also contains prescribing information and storage instructions. The product should be kept out of the reach of children as the packaging is not child resistant.*

FDA Label Image

Label5.jpg (Label5)

This is a description of Donepezil Hydrochloride Tablet, USP 5 mg manufactured by HETERO LABS LIMITED, Mahaboob Nagar, India. The National Drug Code (NDC) for this product is 68554-5037-4. The tablet contains Donepezil Hydrochloride as its main ingredient and is used for the treatment of dementia, specifically Alzheimer's disease. There are several lines of unclear text in the description that cannot be deciphered.*

FDA Label Image

Label6.jpg (Label6)

This text contains NDC codes and other identification numbers related to Donepezil Hydrochloride tablets in 10mg strength. There is also mention of the manufacturer, Hetero Labs, and its address in India. There are some other characters and symbols that appear to be unclear or possibly unreadable, making it difficult to derive meaningful information from the text.*

FDA Label Image

Structure.jpg (Structure)

FDA Label Image

Address.jpg (Address)

Heterolabs Limited is a company located in Mahaboob Nagar, India with the address Unit V, Polepally, Jadcheria. The also provided the company registration number 2012661.*

FDA Label Image

Address1.jpg (Address1)

This is a pharmaceutical product manufactured by Hetero Labs Limited based in India with an address at P Tadcherta, Pally, Mahaboob Nagar. The product name and details are not provided in the given text.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.